Lisdexamfetamine Dimesylate Capsule
Product Images NDC 72162-2457

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Lisdexamfetamine Dimesylate (NDC 72162-2457). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl721622457)

This is a description of a medication package insert for Lisdexamfetamine 60 mg capsules. It provides important information such as the NDC code, dosage equivalence, storage instructions, manufacturer details, and a reminder to dispense the medication guide to patients. The text also highlights temperature storage requirements (15° to 30°C) and advises to keep the medication out of reach of children.*

FDA Label Image

Chemical Structure (Lisdexcaps 01)

FDA Label Image

Figure 1 (Lisdexcaps 02)

This information appears to be related to a study or evaluation involving special populations, potentially focusing on gender, age, renal impairment severity levels, end-stage renal disease, and fold change with a 90% confidence interval. The text also mentions the calculation of change relative to a reference point.*

FDA Label Image

Figure 2 (Lisdexcaps 03)

This is a list of drugs (Guanfacine, Venlafaxine, and Omeprazole) with their corresponding measurements in terms of Cmax and AUC values. The text also mentions "Fold Change and 90% CI" which indicates a change in values and confidence intervals. It seems to be a comparison or evaluation of these drugs based on their pharmacokinetic parameters.*

FDA Label Image

Figure 3 (Lisdexcaps 04)

The text provided does not contain any readable information.*

FDA Label Image

Figure 4 (Lisdexcaps 05)

This text provides information about LS Mean (SE) SKAMP Deportment Scores at different time points post-dose for both a placebo and lisdexamfetamine. The scores are likely related to evaluating behavior or attention levels in a study or research.*

FDA Label Image

Figure 5 (Lisdexcaps 06)

FDA Label Image

Figure 6 (Lisdexcaps 07)

FDA Label Image

Figure 7 (Lisdexcaps 08)

FDA Label Image

Figure 8 (Lisdexcaps 09)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.